Qube Research & Technologies (QRT)’s 9 Meters Biopharma NMTR Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio NMTR Stock Details NMTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-11,767	Closed	-$51K	–	3157
2022 Q3	$51K	Sell	11,767 -2,623	-18%	-$13K	﹤0.01%	2134
2022 Q2	$75K	Buy	+14,390	New	+$136K	﹤0.01%	2037
2021 Q3	–	Sell	-13,733	Closed	-$302K	–	2949
2021 Q2	$302K	Buy	13,733 +2,923	+27%	+$71.8K	﹤0.01%	1577
2021 Q1	$253K	Buy	10,810 +8,128	+303%	+$250K	﹤0.01%	1546
2020 Q4	$46K	Sell	2,682 -8,930	-77%	-$149K	﹤0.01%	1701
2020 Q3	$189K	Buy	11,612 +8,976	+341%	+$109K	﹤0.01%	1412
2020 Q2	$30K	Buy	+2,636	New	+$29.7K	﹤0.01%	1646

Other funds holding NMTR

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

ODFS

O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

Qube Research & Technologies (QRT)'s NMTR Position: Q4 2022 in Review

Qube Research & Technologies (QRT) sold out of 9 Meters Biopharma (NMTR) in Q4 2022, closing a stake of 11,767 shares — an estimated $51K sold.

Qube Research & Technologies (QRT) first reported a position in NMTR in Q2 2020 and held it in 7 quarters. The position peaked at $302K in Q2 2021. 42 funds tracked by Wall St. Rank hold NMTR as of Q4 2022.

Qube Research & Technologies (QRT) reported no remaining 9 Meters Biopharma position as of Q4 2022 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 11,767 9 Meters Biopharma shares in Q4 2022, an estimated $51K.
Qube Research & Technologies (QRT) first reported a position in 9 Meters Biopharma in Q2 2020 and held it in 7 quarters.
Qube Research & Technologies (QRT)'s 9 Meters Biopharma position peaked at $302K in Q2 2021.
42 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2022.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2022, filed 14 Feb 2023.